imiclopazine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
3758 7224-08-0

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • imiclopazine dihydrochloride
  • imiclopazine hydrochloride
  • chlorimiphenine
  • chlorimpiphenin
  • chlorimpiphenine
  • imiclopazin
  • imiclopazine
  • Molecular weight: 486.08
  • Formula: C25H32ClN5OS
  • CLOGP: 4.44
  • LIPINSKI: 0
  • HAC: 6
  • HDO: 0
  • TPSA: 33.27
  • ALOGS: -3.81
  • ROTB: 7

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 3.895 Moderate 0.71
caco2-efflux Caco-2 efflux ratio (BA/AB) 1.343 Moderate 0.71
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 26.062 10^-6 cm/s Moderate 0.71
dh-clint Dog hepatocyte intrinsic clearance 52.966 uL/min/10^6 cells Moderate 0.71
dppb Dog plasma protein binding (% unbound) 1.110 % Moderate 0.71
fcs-ppb Fetal calf serum protein binding (% unbound) 2.550 % Moderate 0.71
herg hERG pIC50 5.965 pIC50 Moderate 0.71
hh-clint Human hepatocyte intrinsic clearance 43.551 uL/min/10^6 cells Moderate 0.71
hlm-clint Human liver microsomal intrinsic clearance 304.789 uL/min/mg protein Moderate 0.71
hppb Human plasma protein binding (% unbound) 0.740 % Moderate 0.71
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 2.415 Moderate 0.71
mh-clint Mouse hepatocyte intrinsic clearance 133.968 Moderate 0.71
mppb Mouse plasma protein binding (% unbound) 1.650 Moderate 0.71
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 9.204 Moderate 0.71
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 4.090 % Moderate 0.71
rh-clint Rat hepatocyte intrinsic clearance 271.644 uL/min/10^6 cells Moderate 0.71
rh-fuinc Rat hepatocyte fraction unbound in incubation 11.300 % Moderate 0.71
rppb Rat plasma protein binding (% unbound) 1.120 % Moderate 0.71
solubility-dd Solubility at pH 7.4 in DMSO 10.839 uM Moderate 0.71

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 7.57 Basic
pKa2 3.57 Basic
pKa3 2.21 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
7414-95-1 SECONDARY_CAS_RN
CHEBI:135784 CHEBI
CHEMBL2105043 ChEMBL_ID
C002916 MESH_SUPPLEMENTAL_RECORD_UI
C0601644 UMLSCUI
2369 INN_ID
23896 PUBCHEM_CID
WGL8B3MDAS UNII

Pharmaceutical products:

None